Dietary Supplements to Treat Radiation-Induced Rectal Injury
Launched by SIXTH AFFILIATED HOSPITAL, SUN YAT-SEN UNIVERSITY · Jan 10, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a dietary supplement called tributyrin (TB) to help treat rectal problems caused by radiation therapy, a condition known as radiation-induced rectal injury. The researchers believe that taking these supplements may reduce symptoms like rectal bleeding and improve the overall quality of life for patients who have had pelvic radiation treatment. To see if the supplements work, the study will measure changes in rectal bleeding and overall health through blood tests and other safe methods, all while ensuring that participants feel comfortable throughout the trial.
To be eligible for this study, participants must be between 18 and 75 years old and should have completed their pelvic radiation therapy at least three months prior. They should also have mild to moderate rectal bleeding but cannot have serious complications or other health issues that could interfere with the study. If you decide to participate, you will receive the supplements and be closely monitored for any changes in your symptoms. This research aims to find a safe and effective way to help patients who are suffering from the side effects of radiation therapy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-75 years
- • At least 3 months since the completion of pelvic radiotherapy
- • No evidence of tumor recurrence or metastasis
- • Rectal bleeding with grade 1-2 by LENT-SOMA scales
- Exclusion Criteria:
- • Acute or chronic infectious diseases
- • Serious systemic diseases
- • Known allergies to any components of the study medication
- • Colonoscopy indicating rectal ulceration (\>1cm2), fistula, stricture, or necrosis
- • Late complications related to pelvic radiation injury
- • Other hemorrhagic or coagulation disorders
- • Previous rectal resection
- • Bowel obstruction or perforation that require surgery
- • Cognitive or psychological disorder
About Sixth Affiliated Hospital, Sun Yat Sen University
The Sixth Affiliated Hospital of Sun Yat-sen University is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a prominent academic hospital, it integrates clinical practice with research excellence, fostering collaboration among multidisciplinary teams to enhance medical knowledge and improve patient outcomes. The hospital is committed to conducting rigorous clinical trials that adhere to the highest ethical standards, aiming to contribute to the global scientific community and support the development of new therapies and interventions. With a focus on translational medicine, the Sixth Affiliated Hospital actively engages in pioneering studies that address critical health challenges and promote evidence-based practices in diverse medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported